Looking for Markers That Predict How Cancer Responds to Radiation Therapy
Studies blood and tumour samples from people with nasopharyngeal or prostate cancer.
Plain-language title generated from the registry record
Registry title: Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Key facts
- Where
- Singapore, SingaporeSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 99 years old?
Source: NCT04340024, who can take part
Where in Singapore
- National Cancer Center SingaporeSingapore, SingaporeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Cancer Centre, Singapore
- Trial code
- NCT04340024
- Record updated
- 11 June 2025
- Original description
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.Read full original descriptionShow less
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
Inclusion: Patients with severe side effects from radiotherapy; Patients with a type of cancer that is associated with sensitivity to radiotherapy.
Exclusion: Age of patient must be between 21 (inclusive) and 99 (exclusive).